IMA Europe Announces Klaus Moeller as Honorary Professor in Management Accounting
IMA® (Institute of Management Accountants), the association of accountants and financial professionals in business, announced today that Klaus Moeller, Ph.D., Professor and Chair of Controlling and Performance Management at the University of St. Gallen in Switzerland, will begin a two-year term as IMA Europe’s Honorary Professor in Management Accounting.
IMA selected Professor Moeller to be IMA’s first Honorary Professor for a variety of reasons. The University of St. Gallen is one of the leading European business schools in international rankings and the first school in Europe to offer an extremely popular elective course for Masters’ students to prepare for the CMA (Certified Management Accountant) exam. Professor Moeller has extensive experience in performance management, predictive analytics and innovation controlling that has helped companies improve their control systems.
“Professor Moeller is one of the most influential thought leaders and business experts in management accounting. He epitomizes IMA’s goals of combining research, practical solutions and teaching to drive management accounting’s value from insight to impact,” said Raef Lawson, Ph.D., CMA, CPA, IMA Vice President of Research and Policy.
In his role, Professor Moeller will support the growth of IMA’s mission, as well as continue to promote the CMA certification in Europe. He will also contribute to Strategic Finance magazine and chair IMA’s symposium at the 2016 Annual Congress of the European Accounting Association in Maastricht, Netherlands, along with other planned speaking engagements on behalf of IMA, including IMA’s 2016 Annual Conference and Expo in Las Vegas and the American Accounting Association Conference (AAA) in New York while continuing his teaching and course responsibilities at the University.
“As IMA continues to expand globally, it has never been more vital to have a presence in Europe by way of Professor Moeller’s role as IMA Honorary Professor,” said Nina Michels-Kim, CMA and Director of European Operations at IMA. “We’re thrilled to welcome him on board as a champion for IMA, the CMA certification and profession as a whole.”
To learn more about the CMA elective course offered exclusively to University of St. Gallen’s master level students, please visit http://www.aca.unisg.ch/en/education/cma/infostudents .
About IMA ® (Institute of Management Accountants)
IMA® , the association of accountants and financial professionals in business, is one of the largest and most respected associations focused exclusively on advancing the management accounting profession. Globally, IMA supports the profession through research, the CMA® (Certified Management Accountant) program, continuing education, networking and advocacy of the highest ethical business practices. IMA has a global network of more than 75,000 members in 140 countries and 300 professional and student chapters. Headquartered in Montvale, N.J., USA, IMA provides localized services through its four global regions: The Americas, Asia/Pacific, Europe, and Middle East/Africa. For more information about IMA, please visit www.imanet.org .
+41 44 500 35 15
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
VERTEX-PHARMACEUTICALS19.10.2018 13:56 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene
TX-SCHLUMBERGER-LIMITED19.10.2018 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2018 Results
CA-TRADESHIFT19.10.2018 13:02 | pressemeddelelse
Tradeshift Announces Q3 2018 Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum